2006
DOI: 10.1016/j.neulet.2005.12.085
|View full text |Cite
|
Sign up to set email alerts
|

Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

11
204
2
7

Year Published

2006
2006
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 353 publications
(224 citation statements)
references
References 23 publications
11
204
2
7
Order By: Relevance
“…These kinases include protein kinase A (PKA), [24][25][26] protein kinase C (PKC), 27 p38 and p44 mitogen-activated protein kinases (MAPK), 28,29 and Ca 2 þ -calmodulin kinase (CaMK) IV. 30 Of relevance to bipolar disorder, BDNF levels are decreased in the serum, 31 and BDNF and phosphorylated CREB levels are decreased in the brain of bipolar patients compared to controls. 32,33 A Val66Met polymorphism in the BDNF gene confers susceptibility to bipolar disorder in humans [34][35][36] and a BDNF-linked complex polymorphic region, which has lower transcriptional activity than other alleles in rat primary cultured neurons, also confers susceptibility to bipolar disorder in humans.…”
Section: Introductionmentioning
confidence: 99%
“…These kinases include protein kinase A (PKA), [24][25][26] protein kinase C (PKC), 27 p38 and p44 mitogen-activated protein kinases (MAPK), 28,29 and Ca 2 þ -calmodulin kinase (CaMK) IV. 30 Of relevance to bipolar disorder, BDNF levels are decreased in the serum, 31 and BDNF and phosphorylated CREB levels are decreased in the brain of bipolar patients compared to controls. 32,33 A Val66Met polymorphism in the BDNF gene confers susceptibility to bipolar disorder in humans [34][35][36] and a BDNF-linked complex polymorphic region, which has lower transcriptional activity than other alleles in rat primary cultured neurons, also confers susceptibility to bipolar disorder in humans.…”
Section: Introductionmentioning
confidence: 99%
“…Family-based association studies show that the Val66Met polymorphism is associated with the diagnosis of BD and the phenomenon of rapid cycling (Green et al, 2006;Lohoff et al, 2005) and early age of illness onset (Tang et al, 2008) in BD patients, albeit some other studies did not show this association (Gratacos et al, 2007;Kanazawa et al, 2007;Kunugi et al, 2004). Moreover, both BD and major depressive disorder (MDD) patients show decreased serum levels of BDNF (Cunha et al, 2006;Karege et al, 2004;Machado-Vieira et al, 2007) compared to healthy subjects, and there is an inverse correlation between BDNF levels and severity of the depressive (Karege et al, 2004;MachadoVieira et al, 2007;Shimizu et al, 2003) and manic states (Cunha et al, 2006). A magnetic resonance study demonstrated that serum BDNF levels are positively associated with the concentration of N-acetyl aspartate, a marker of neuronal integrity, and choline, a marker of cell membrane turnover, in the anterior cingulate cortex (ACC) (Lang et al, 2007), suggesting that peripheral BDNF content may be a potential marker of cerebral cortical integrity.…”
Section: Introductionmentioning
confidence: 99%
“…71 Altered BDNF levels and genetic expression are well documented in schizophrenia 12 and BD, 72,73 and are associated with episodes as well as with length of illness. 12,13,73 Interestingly, BDNF has also been implicated in energy metabolism. 74 The Val66Met polymorphism of the BDNF gene is associated with a higher body mass index (BMI) in healthy individuals.…”
Section: Metabolic Systems Involved In the Pathophysiology Of Psychiamentioning
confidence: 99%
“…Reductions in neurotrophins, such as brain-derived neurotrophic factor (BDNF), have been repeatedly demonstrated in schizophrenia 12 and BD both during mood episodes and in periods of euthymia. 13 Similarly, altered peripheral levels of mediators involved in the regulation of neuroplasticity, such as factors of apoptosis and inflammation markers, have been documented in schizophrenia 14,15 and in BD. [16][17][18] Recently, several authors have proposed that schizophrenia and BD are progressive in nature, with substantial differences between early and late stages in terms of clinical presentation, treatment response, and neurobiological characteristics.…”
Section: Introductionmentioning
confidence: 99%